In 2007, five years before Proscar and Propecia warning labels were required to be updated by the FDA to include information on sexual side effects, an important paper was published in Clinical Therapeutics by MJ Naslund titled “A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.”.

This…

Just a quick note about a finasteride study I recently read in Archives of Internal Medicine.  For clarity, finasteride is the active chemical in the hair loss drug Propecia and the benign prostatic hyperplasia (BPH) drug Proscar, and both Propecia and Proscar are manufactured by Merck & Co., Inc.

This study, titled “…

Though the warning labels for Propecia (finasteride 1mg) and Proscar (finasteride 5mg) were not updated to include information about long-term sexual side effects until April, 2012, research has been available to the public for over a decade that shows finasteride is connected with such adverse effects.  Here, we discuss an article appearing in the November…

An article from the October, 1999 edition of Urology went great lengths to provide important insight into the connection between finasteride (the active chemical in Propecia, Proscar, and other drugs) and sexual side-effects.  This article is titled “Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia.

In 2010, an article appearing in the October edition of medical journal The Cochrane Database of Systematic Reviews titled “Finasteride for benign prostatic hyperplasia.” helps us further understand the connection between use of finasteride (the active chemical in benign prostatic hyperplasia drug Proscar) and adverse sexual side effects.

This research team, led by…

In 1996, that is, 16 years before the FDA required that Merck & Co., Inc. update warning labels for products containing finasteride, such as the hair loss drug Propecia and the BPH drug Proscar, a study by S.C. Chueh et al. was published in The Journal of The Formosan Medical Association titled “Treating benign…

Published in 2011 – over a year prior to Propecia Warning Label Updates, a paper by A.M. Traish et al. titled “Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.” illustrated important connections between chemicals like finasteride (the active ingredient in drugs…

Published in the January, 2013 edition of Expert Opinion on Drug Safety, an article by S. Gur and a team of researchers from Tulane University (New Orleans) titled “Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.” provides important insight into the connection between finasteride (Propecia, Proscar, others) and…